Paper24201019
Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions.
Wang X and 5 others. J Ethnopharmacol, 2013. Cited by 206 papers, by iCite.
Cite this record
ConductScience Library. Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions. Papers, record 24201019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24201019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycyrrhiza | Major topic |
| Herb-Drug Interactions | Major topic |
| Medicine, Chinese Traditional | Major topic |
| Animals | |
| Cytochrome P-450 Enzyme System | |
| Humans | |
| Membrane Transport Proteins |
Source PubMed
Cited by106
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42519194 | Case Report: Delirium and complications resulting from the abuse of compound liquorice tablets. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42519194 | PubMed |
| 42421515 | Interactions between cytochrome P450 enzymes and traditional Chinese herbs: A comprehensive review. | J Chin Med Assoc | 2026 | https://conductscience.org/library/papers/42421515 | PubMed |
| 41268233 | Mechanism of action and research advancements of Qi-tonifying traditional Chinese medicine in the treatment of type 2 diabetic mellitus. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/41268233 | PubMed |
| 40108906 | The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis. | Cardiovasc Hematol Disord Drug Targets | 2025 | https://conductscience.org/library/papers/40108906 | PubMed |
| 40033496 | Dry Powder Inhaler of Sustained-Release Microspheres Containing Glycyrrhizin: Factorial Design and Optimization. | Comb Chem High Throughput Screen | 2026 | https://conductscience.org/library/papers/40033496 | PubMed |
| 39850390 | Pro-angiogenic effects of Guo Min decoction in a zebrafish model. | Tzu Chi Med J | 2025 | https://conductscience.org/library/papers/39850390 | PubMed |
| 39625590 | Biological insights and therapeutic potential of Glycyrrhiza uralensis and its bioactive compounds: an updated review. | Arch Pharm Res | 2024 | https://conductscience.org/library/papers/39625590 | PubMed |
| 39397991 | Glycyrrhetinic acid reduces lung inflammation caused by pneumococcal infection by reducing the toxicity of pneumolysin. | Heliyon | 2024 | https://conductscience.org/library/papers/39397991 | PubMed |
| 39267390 | Increased risk of major adverse cardiovascular events in young and middle-aged adults with obesity receiving Chinese herbal medicine: A nationwide cohort study. | J Chin Med Assoc | 2024 | https://conductscience.org/library/papers/39267390 | PubMed |
| 39149015 | Effect of Glycyrrhiza uralensis crude water extract on the expression of Nitric Oxide Synthase 2 gene during myogenesis. | Heliyon | 2024 | https://conductscience.org/library/papers/39149015 | PubMed |
| 38771510 | Glycyrrhizic Acid Alleviates Semen Strychni-Induced Neurotoxicity Through the Inhibition of HMGB1 Phosphorylation and Inflammatory Responses. | J Neuroimmune Pharmacol | 2024 | https://conductscience.org/library/papers/38771510 | PubMed |
| 38584602 | AI-assisted literature exploration of innovative Chinese medicine formulas. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38584602 | PubMed |
| 38045204 | Evaluation of antioxidant activity and heavy metals content in licorice (Glycyrrhiza glabra L.) growing wild in Armenia. | Heliyon | 2023 | https://conductscience.org/library/papers/38045204 | PubMed |
| 37958031 | The Power of Licorice (Radix glycyrrhizae) to Improve Oral Health: A Comprehensive Review of Its Pharmacological Properties and Clinical Implications. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/37958031 | PubMed |
| 37894521 | Multi-Omics Elucidates Difference in Accumulation of Bioactive Constituents in Licorice (Glycyrrhiza uralensis) under Drought Stress. | Molecules | 2023 | https://conductscience.org/library/papers/37894521 | PubMed |
| 37892843 | Systematic Myostatin Expression Screening Platform for Identification and Evaluation of Myogenesis-Related Phytogenic in Pigs. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/37892843 | PubMed |
| 37836809 | Pharmacological Mechanisms and Adjuvant Properties of Licorice Glycyrrhiza in Treating Gastric Cancer. | Molecules | 2023 | https://conductscience.org/library/papers/37836809 | PubMed |
| 37764649 | Liquorice Toxicity: A Comprehensive Narrative Review. | Nutrients | 2023 | https://conductscience.org/library/papers/37764649 | PubMed |
| 37727691 | Progress in the mechanism of autophagy and traditional Chinese medicine herb involved in alcohol-related liver disease. | PeerJ | 2023 | https://conductscience.org/library/papers/37727691 | PubMed |
| 37680778 | A Case of Liquorice-Infused Marijuana Causing Syndrome of Apparent Mineralocorticoid Excess. | Eur J Case Rep Intern Med | 2023 | https://conductscience.org/library/papers/37680778 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24201019
GET https://conductscience.org/api/papers/v1/24201019/cited_by?page=2